Last reviewed · How we verify
Ultibro Breezhaler with oral charcoal
Ultibro Breezhaler with oral charcoal is a Small molecule drug developed by Orion Corporation, Orion Pharma. It is currently in Phase 1 development.
At a glance
| Generic name | Ultibro Breezhaler with oral charcoal |
|---|---|
| Sponsor | Orion Corporation, Orion Pharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ultibro Breezhaler with oral charcoal CI brief — competitive landscape report
- Ultibro Breezhaler with oral charcoal updates RSS · CI watch RSS
- Orion Corporation, Orion Pharma portfolio CI
Frequently asked questions about Ultibro Breezhaler with oral charcoal
What is Ultibro Breezhaler with oral charcoal?
Ultibro Breezhaler with oral charcoal is a Small molecule drug developed by Orion Corporation, Orion Pharma.
Who makes Ultibro Breezhaler with oral charcoal?
Ultibro Breezhaler with oral charcoal is developed by Orion Corporation, Orion Pharma (see full Orion Corporation, Orion Pharma pipeline at /company/orion-corporation-orion-pharma).
What development phase is Ultibro Breezhaler with oral charcoal in?
Ultibro Breezhaler with oral charcoal is in Phase 1.